
Catafly 2mg / ml suspension 140 ml
Tradename
Catafly
Catafly
Composition
Each ml of syrup contains:
2 mg diclofenac potassium
Auxiliary components:
Cytic acid, sorbitic acid, purified water, strawberry flavor, microcrystalline cellulose, propylene glycol, sodium saccharin, and sorbitol.
Properties
NSAID, a derivative of phenylacetic acid. It has a pronounced analgesic, anti-inflammatory and antipyretic effect. Due to its fast onset of action, the use of diclofenac potassium salt is preferred for the treatment of acute pain an inflammatory conditions.
The main mechanism of action of diclofenac is the inhibition of the synthesis of prostaglandins, which play an important role in the pathogenesis of inflammation, pain and fever.
Indications
For short-term treatment of the following acute conditions: post-traumatic pain, inflammation and swelling, for example, due to damage to the ligaments; postoperative pain, inflammation and swelling, for example, after dental or orthopedic surgery; pain and / or inflammation accompanying gynecological diseases, for example, primary dysmenorrhea or adnexitis; headache, migraine attacks; toothache; pain syndromes from the spine; pain in muscles and joints; neuralgia; rheumatic diseases of extra-articular soft tissues; proctitis; renal colic; biliary colic; as an adjuvant in infectious and inflammatory diseases of the ear, throat and nose, for example, pharyngotonsillitis, otitis media, accompanied by severe pain and inflammation.
Method of administration and dosage:
For adults:
Contraindications
Hypersensitivity (including to other NSAlDs • attacks of bronchial asthma, urticaria or acu rhinitis in history caused by taking acetylsalicylic acid or other NSAlDs; peptic
ulcer or intestinal ulcer in the acute phase; ulcerative bleeding or perforation; inflammatory bowel disease (Crohn’s disease, ulcerative colitis) in the acute phase; severe liver failure; active liver disease; severe renal failure (CC less than 30 ml / min); progressive kidney disease; confirmed hyperkalemia; severe heart failure; period after coronary artery bypass grafting; disorders of hematopoiesis; various disorders of hemostasis (including hemophilia);
Precautions:
Side effects
From the nervous system: often — headache, dizziness; rarely — drowsiness; very rarely
paresthesias, memory disorders, tremors, convulsions, anxiety, acute cerebrovascular accidents, aseptic meningitis, disorientation, depression, insomnia, nightmares, irritability, mental disturbances, disturbances in taste.
On the part of the organ of hearing and labyrinth disorders: often — vertigo; very rarely hearing impairment, tinnitus.